Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obesity
Biotech
Eli Lilly taps Camurus' tech to advance long-acting obesity meds
With the deal, Lilly can use Camurus' long-acting delivery technology on up to four of its own incretin compounds.
Zoey Becker
Jun 3, 2025 5:04pm
Regeneron pens $2B pact for Hansoh's potential rival to Zepbound
Jun 2, 2025 8:20am
Biomea cuts staff, drops leukemia asset in metabolic shift
May 5, 2025 6:59pm
FDA lifts hold on Amgen's phase 1 obesity study
May 2, 2025 10:10am
Relmada reconsiders plans to test psilocybin for obesity
Mar 28, 2025 10:00am
Novo pens $2B deal for triple agonist weight loss drug
Mar 24, 2025 9:50am
